In support, siRNA silencing of RAC/CDC42 regulating GEFs, such as PIP3-dependent Rac exchanger 1 (PREX1) and vav guanine nucleotide exchange factor 3 (VAV3), can significantly reduce prostate cancer cell proliferation and migration in vitro [290,291]. Here, VAV3 is linked to prostate carcinoma.